Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Product Description Compound Specifications Full Name: Retatrutide Analog (GLP3-R) Sequence Type: Multi-receptor incretin-associated peptide analog Target Pathways: GLP-1, GIP, and glucagon receptor signaling Molecular Weight: ~4731 g/mol Structure Notes: Structurally modified peptide analog incorporating targeted amino acid substitutions and lipidation to support prolonged receptor interaction and signaling stability Overview GLP3-R is a multi-receptor peptide analog frequently incorporated into experimental models examining how coordinated GLP-1 , GIP , and glucagon receptor signaling influences nutrient-responsive metabolic systems
The compounding pharmacy, not the FDA, assigns this date based on available stability data, USP guidelines, and the specific characteristics of their formulation
NICE guidelines (NG28) recommend regular blood glucose monitoring during treatment transitions to prevent hyperglycaemia and ensure metabolic stability
Two commonly referenced comparison compounds are semaglutide and tirzepatide, which represent single receptor and dual receptor incretin agonist designs respectively
At KAST Medical Aesthetics, we offer comprehensive B12 testing and injections to help you achieve and maintain the best possible health
US$ 25.48
US$ 26.19
US$ 22.40
US$ 22.88
/product/09/360676/1.jpg?6796)
